Literature DB >> 2858525

The nasal absorption of sodium cromoglycate in the albino rat.

A N Fisher, K Brown, S S Davis, G D Parr, D A Smith.   

Abstract

The intranasal absorption of sodium cromoglycate has been investigated in the adult male COBS/Wistar rat. Sodium cromoglycate (1 mg kg-1) was instilled into the nasal cavities and for comparison animals were also similarly dosed intravenously or sub-lingually. Serial samples of blood or bile were collected. After intravenous administration, the area under the plasma concentration curve (AUC0-infinity) was 32 micrograms min ml-1 corresponding to a plasma clearance of 13 ml min-1 and an elimination rate constant of 0.049 min-1. Plasma concentrations of radioactivity after intranasal administration rose to a mean peak of 0.3 micrograms ml-1 approximately 20 min after dosing and fell to 0.03 micrograms min ml-1 at 3 h. The AUC0-3 was 19 micrograms min ml-1 corresponding to an absorption of 60% over 3 h. The absorption rate constant (ka) was 0.059 min-1. The total amount of sodium cromoglycate excreted in bile after intravenous administration was 56%. The amount of compound excreted in the bile was 30% after intranasal administration corresponding to an absorption of 53%. Plasma and bile data therefore show good agreement. Total excretion in the bile over 3 h after sub-lingual administration was 3%, demonstrating that this route made no significant contribution to the intranasal results. The absorption of sodium cromoglycate is independent of variations in the technique including changes in the orientation of the rat or blocking of the nasopalatine. The techniques used minimized other competing nasal clearance processes such as mucociliary clearance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858525     DOI: 10.1111/j.2042-7158.1985.tb04927.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

1.  Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption.

Authors:  M D Donovan; G L Flynn; G L Amidon
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

2.  The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model.

Authors:  L Illum; M Hinchcliffe; S S Davis
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

3.  Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats.

Authors:  M J Deurloo; W A Hermens; S G Romeyn; J C Verhoef; F W Merkus
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

4.  Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model.

Authors:  Stuart T Charlton; Joanne Whetstone; Susan T Fayinka; Kevin D Read; Lisbeth Illum; Stanley S Davis
Journal:  Pharm Res       Date:  2008-02-22       Impact factor: 4.200

5.  Nasal absorption enhancement of 17 beta-estradiol by dimethyl-beta-cyclodextrin in rabbits and rats.

Authors:  W A Hermens; M J Deurloo; S G Romeyn; J C Verhoef; F W Merkus
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

6.  Mechanisms of nerve growth factor signaling in bone nociceptors and in an animal model of inflammatory bone pain.

Authors:  Sara Nencini; Mitchell Ringuet; Dong-Hyun Kim; Yu-Jen Chen; Claire Greenhill; Jason J Ivanusic
Journal:  Mol Pain       Date:  2017-01       Impact factor: 3.395

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.